Clinical trial
Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy Using a Novel Device
NCT04482062 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy Using a Novel Device
- Lead sponsor
- Edwards Lifesciences
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- April 9, 2021
- Completion date
- June 27, 2030
- Enrollment
- 864 (actual)
- Sites
- 62
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular diseases, heart failure, heart valve diseases, tricuspid valve disease, tricuspid valve insufficiency, tricuspid valve regurgitation